May 8, 2013
  • Does Azithromycin Raise Cardiac Risks in the
    General Population?

    While an earlier study out of Tennessee found that use of azithromycin substantially raised the risk of cardiac events in Medicaid patients, a newer study out of Denmark says a similar effect was not found in the general population there. What does this study say about its differences from the earlier research?

  • Abuse-Deterrent Pseudoephedrine Products Becoming More Widely Available

    With illegal methamphetamine production on the rise despite measures to combat it, abuse-deterrent pseudoephedrine formulations are the latest weapons in that drug war. Find out how they work and where they are available.

  • Painkiller Use Before German Marathon Resulted in
    More Adverse Effects

    Managing pain is a crucial issue for long-distance runners and other endurance athletes. A report based on a survey at the 2010 Bonn Marathon/Half-Marathon raises issues, however, on the use of painkillers before a big event. Find out what the report authors had to say about the higher rate of adverse events in runners who had medicated before the race.

  • Perioperative Use of Beta-Blockers Decreased Cardiac Illness, Mortality

    While the use of perioperative beta-blockers may be both controversial and on the decline, a new study found that the antihypertensive agents significantly decreased 30-day mortality and cardiac illness in noncardiac, nonvascular surgery. Here are the details.

U.S. Pharmacist Social Connect